BioVersys AG (XSWX:BIOV) Total Assets: CHF90.64 Mil (As of Dec. 2025)


XSWX:BIOV BioVersys AG XSWX:BIOV
4 GF Score
Price CHF26.30
View Full Analysis

What is BioVersys AG Total Assets?

BioVersys AG XSWX:BIOV -2.59% 4 Total Assets is CHF90.64 Mil as of Dec. 2025. GuruFocus rates XSWX:BIOV with a GF Score™ of 4/100.

BioVersys AG's Total Assets for the quarter that ended in Dec. 2025 was CHF90.64 Mil.

During the past 12 months, BioVersys AG's average Total Assets Growth Rate was 247.90% per year.

Total Assets is connected with ROA %. BioVersys AG's annualized ROA % for the quarter that ended in Dec. 2025 was -23.35%. Total Assets is also linked to Revenue through Asset Turnover. BioVersys AG's Asset Turnover for the quarter that ended in Dec. 2025 was 0.01.

BioVersys AG  (XSWX:BIOV) Total Assets Explanation

Total Assets is connected with ROA %.

BioVersys AG's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-21.64/( (94.722+90.636)/ 2 )
=-21.64/92.679
=-23.35 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

BioVersys AG's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.8/( (94.722+90.636)/ 2 )
=0.8/92.679
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

BioVersys AG Total Assets Related Terms

BioVersys AG Total Assets Historical Data

* Premium members only.

The historical data trend for BioVersys AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVersys AG Total Assets Chart

BioVersys AG Annual Data
Trend Dec24 Dec25
Total Assets
34.96 90.64

BioVersys AG Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
Total Assets 0.00 34.96 94.72 90.64
XSWX:BIOV
4GF Score
BioVersys AG XSWX:BIOV
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioVersys AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

BioVersys AG's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=59.811+30.825
=90.64

BioVersys AG's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=59.811+30.825
=90.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of CHF90.64 Mil mean?
BioVersys AG (XSWX:BIOV) has a Total Assets of CHF90.64 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on BioVersys AG and its competitors.
Is BioVersys AG's Total Assets too high?
BioVersys AG's current Total Assets is CHF90.64 Mil. Overall, BioVersys AG has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's Total Assets compare to VRTX and REGN?
BioVersys AG's Total Assets of CHF90.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on BioVersys AG and its competitors. BioVersys AG's current Total Assets is CHF90.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (XSWX:BIOV) has a current Total Assets of CHF90.64 Mil. The current Total Assets is CHF90.64 Mil. BioVersys AG's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For BioVersys AG (XSWX:BIOV), the current Total Assets is CHF90.64 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioVersys AG Business Description

Other Exchanges BIOVz:UKW33:Germany
Address c/o Technologiepark, Hochbergerstrasse 60c, Basel, CHE, CH-4057
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
4GF Score

Get the complete analysis for XSWX:BIOV

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF26.30
Price